-
1
-
-
85081469599
-
-
(in press).
-
For Part 2 see Mewshaw, R. E.; Shi, X.; Mazandarani, H.; Coupet, J.; McGaughey, G.; Andree, T. Bioorg. Chem. Med. Lett. 1998, (in press).
-
(1998)
Bioorg. Chem. Med. Lett.
-
-
Mewshaw, R.E.1
Shi, X.2
Mazandarani, H.3
Coupet, J.4
McGaughey, G.5
Andree, T.6
-
2
-
-
6844258179
-
-
For Part 1 see Mewshaw, R. E.; Kavanagh, J.; Stack, G.; Marquis, K.; Shi, X.; Kagan, M. Z.; Webb, M. B.; Katz, A. H.; Park, A.; Kang, Y. H.; Abou-Gharbia, M.; Scerni, R.; Wasik, T.; Cortes-Burgos, L.; Spangler, T.; Brennan, J. A.; Pielsa, M.; Mazandarani, H.; Cockett, M. I.; Ochalski, R.; Coupet, J.; Andree, T. J. Med. Chem. 1997, 40, 4235.
-
(1997)
J. Med. Chem.
, vol.40
, pp. 4235
-
-
Mewshaw, R.E.1
Kavanagh, J.2
Stack, G.3
Marquis, K.4
Shi, X.5
Kagan, M.Z.6
Webb, M.B.7
Katz, A.H.8
Park, A.9
Kang, Y.H.10
Abou-Gharbia, M.11
Scerni, R.12
Wasik, T.13
Cortes-Burgos, L.14
Spangler, T.15
Brennan, J.A.16
Pielsa, M.17
Mazandarani, H.18
Cockett, M.I.19
Ochalski, R.20
Coupet, J.21
Andree, T.22
more..
-
3
-
-
0027049395
-
-
Lahti, R. A.; Figur, L. M.; Peircey, M. F.; Ruppel, P. L.; Evans, D. L. Mol. Pharm. 1992, 42, 432.
-
(1992)
Mol. Pharm.
, vol.42
, pp. 432
-
-
Lahti, R.A.1
Figur, L.M.2
Peircey, M.F.3
Ruppel, P.L.4
Evans, D.L.5
-
5
-
-
85081474565
-
-
i values are the means of n = 2-3 experiments run at nine different concentrations. Each experiment was carried out in triplicate. 95% confidence limits were generally <± 15 % of the mean value.
-
i values are the means of n = 2-3 experiments run at nine different concentrations. Each experiment was carried out in triplicate. 95% confidence limits were generally <± 15 % of the mean value.
-
-
-
-
6
-
-
0001672496
-
-
Usdin, E., Kopin, I., Barchas, J., Eds. ; Pergamon: New York
-
McDermed, J. D. ; Freeman, H. S. Catecholamines: Basic and Clinical Frontiers; Usdin, E., Kopin, I., Barchas, J., Eds. ; Pergamon: New York, 1979; Vol. 1, p 568.
-
(1979)
Catecholamines: Basic and Clinical Frontiers
, vol.1
, pp. 568
-
-
McDermed, J.D.1
Freeman, H.S.2
-
7
-
-
85081469846
-
-
pKa calculations were performed using the CompuDrug software package version 3.1 (Chemistry Ltd., pKalc).
-
pKa calculations were performed using the CompuDrug software package version 3.1 (Chemistry Ltd., pKalc).
-
-
-
|